Who are the key players in the Cyramza (Ramucirumab) Market Report 2026 market?

Major companies operating in the Cyramza (Ramucirumab) Market Report 2026 market are Major companies operating in the cyramza (ramucirumab) market are Eli Lilly and Company Read More

What are the major opportunities in the Cyramza (Ramucirumab) market? What are the strategies for the Cyramza (Ramucirumab) market?

For detailed insights on the major opportunities and strategies in the Cyramza (Ramucirumab) market, Read More

How does the Cyramza (Ramucirumab) market relate to the overall economy and other similar markets?

For detailed insights on Cyramza (Ramucirumab)'s relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Cyramza (Ramucirumab) industry?

For detailed insights on the mergers and acquisitions in the Cyramza (Ramucirumab) industry, Read More

What are the key dynamics influencing the Cyramza (Ramucirumab) market growth? SWOT analysis of the Cyramza (Ramucirumab) market.

For detailed insights on the key dynamics influencing the Cyramza (Ramucirumab) market growth and SWOT analysis of the Cyramza (Ramucirumab) industry, Read More

Cyramza (Ramucirumab) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Cyramza (Ramucirumab) Market Report 2026

Name: Cyramza (Ramucirumab) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Cyramza (Ramucirumab) Market Overview

• The Cyramza (Ramucirumab) market growth in the historic period has been driven by approval for gastric and colorectal cancers, rising global cancer burden

• Market expansion is supported by increasing incidence of solid tumors, expansion into new oncology indications

• Growth Driver: Rising Cancer Incidence Fuels Growth Of Cyramza (Ramucirumab) Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cyramza (Ramucirumab) Market?

Cyramza (ramucirumab) is a monoclonal antibody used in cancer treatment. It works by targeting and inhibiting the vascular endothelial growth factor receptor 2 (VEGFR-2), which helps prevent tumor blood vessel formation. It is commonly used to treat various cancers, including gastric, colorectal, and lung cancer.

The main types of cyramza (ramucirumab) are 100mg/Box, 500mg/Box. 100 mg/box refers to the packaging size of Cyramza (Ramucirumab) where each box contains 100 mg of the drug. It is often used for patients requiring a lower dose of the medication for cancer treatment. The smaller packaging allows for easier distribution and use in various medical settings. It has various applications in advanced gastric cancer, GEJ adenocarcinoma, non-small cell lung carcinoma, metastatic colorectal cancer (MCRC), and hepatocellular carcinoma (HCC) and utilized by end users such as hospitals, cancer treatment centers, ambulatory surgical centers, and research institutes.

Cyramza (Ramucirumab) Market Global Report 2026 Market Report bar graph

What Is The Cyramza (Ramucirumab) Market Size and Share 2026?

The cyramza (ramucirumab) market size has grown strongly in recent years. It will grow from $1.31 million in 2025 to $1.4 million in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to approval for gastric and colorectal cancers, rising global cancer burden, clinical success of vegfr inhibitors, hospital oncology adoption, limited late stage treatment options.

What Is The Cyramza (Ramucirumab) Market Growth Forecast?

The cyramza (ramucirumab) market size is expected to see strong growth in the next few years. It will grow to $1.79 million in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing incidence of solid tumors, expansion into new oncology indications, growth of targeted cancer therapies, rising oncology healthcare spending, improved diagnostic rates. Major trends in the forecast period include growing use of anti angiogenic therapies, expansion across multiple cancer indications, combination use with chemotherapy, rising demand in advanced stage cancers, hospital based oncology administration.

Book your 30 minutes free consultation with our research experts

Global Cyramza (Ramucirumab) Market Segmentation

1) By Type: 100mg/Box, 500mg/Box

2) By Application: Advanced Gastric Cancer, GEJ Adenocarcinoma, Non-small Cell Lung Carcinoma, Metastatic Colorectal Cancer (mCRC), Hepatocellular Carcinoma (HCC)

3) By End-User: Hospitals, Cancer Treatment Centers, Ambulatory Surgical Centers, Research Institutes

What Are The Drivers Of The Cyramza (Ramucirumab) Market?

The rising incidence of cancer is expected to propel the growth of the Cyramza (ramucirumab) market going forward. Cancer refers to a group of diseases characterized by uncontrolled cell growth and spread to other parts of the body. The rise in cancer cases can be attributed to factors such as an aging population, lifestyle choices, environmental exposures, improved detection methods, and genetic predispositions. Cyramza (ramucirumab) is used in cancer treatment to target and inhibit the vascular endothelial growth factor receptor 2 (VEGFR-2), helping to prevent tumor blood vessel growth and slow cancer progression. For instance, in August 2024, according to a report published by the Australian Institute of Health and Welfare, an Australia-based national agency for information and statistics on Australia's health and welfare, by 2034, Australia is projected to have approximately 209,000 new cancer diagnoses, a significant increase from the estimated 169,000 cases expected in 2024, reflecting the impact of a growing population and rising cancer rates. Additionally, in 2024, cancer is anticipated to account for about 3 out of every 10 deaths in the country. Therefore, the rising incidence of cancer is driving the growth of the cyramza (ramucirumab) industry.

The rise in aging population is expected to drive the growth of the Cyramza (Ramucirumab) market going forward. An aging population refers to a growing proportion of older individuals within a society due to increased life expectancy and declining birth rates. The aging population is increasing due to advancements in healthcare that have extended life expectancy. Cyramza (Ramucirumab) is used by the aging population to help treat advanced cancers by blocking blood vessel growth that fuels tumor progression. For instance, in January 2024, according to the Population Reference Bureau, a US-based non-profit organization, reported that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. As a result, this age group’s proportion of the total U.S. population will grow from 17% to 23% during this period. Therefore, the rise in aging population is driving the growth of the Cyramza (Ramucirumab) industry.

The increasing adoption of personalized medicine is expected to drive the growth of the Cyramza (Ramucirumab) market going forward. Personalized medicine is a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment rather than using a one-size-fits-all method. Personalized medicine is increasing due to advances in genetic testing that allow treatments to be tailored to individual patient profiles. Cyramza (Ramucirumab) is used as personalized medicine by targeting specific tumor pathways in patients whose cancer shows biomarkers responsive to VEGFR-2 inhibition. For instance, in February 2024, Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the Cyramza (Ramucirumab) industry.

Key Players In The Global Cyramza (Ramucirumab) Market

Major companies operating in the cyramza (ramucirumab) market are Eli Lilly and Company

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the cyramza (ramucirumab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Cyramza (Ramucirumab) Market?

The cyramza (ramucirumab) market consists of sales of cyramza (ramucirumab) iv infusion and combination therapy formulations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cyramza (Ramucirumab) Market Report 2026?

The cyramza (ramucirumab) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cyramza (ramucirumab) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Cyramza (Ramucirumab) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	CAGR of 6.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Eli Lilly and Company
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cyramza (Ramucirumab) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cyramza (Ramucirumab) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cyramza (Ramucirumab) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cyramza (Ramucirumab) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Use Of Anti Angiogenic Therapies

4.2.2 Expansion Across Multiple Cancer Indications

4.2.3 Combination Use With Chemotherapy

4.2.4 Rising Demand In Advanced Stage Cancers

4.2.5 Hospital Based Oncology Administration

5. Cyramza (Ramucirumab) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Treatment Centers

5.3 Oncology Clinics

5.4 Academic Medical Centers

5.5 Research Institutes

6. Cyramza (Ramucirumab) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cyramza (Ramucirumab) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cyramza (Ramucirumab) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cyramza (Ramucirumab) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cyramza (Ramucirumab) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cyramza (Ramucirumab) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cyramza (Ramucirumab) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cyramza (Ramucirumab) Market Segmentation

9.1. Global Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

100mg/Box, 500mg/Box

9.2. Global Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Advanced Gastric Cancer, GEJ Adenocarcinoma, Non-small Cell Lung Carcinoma, Metastatic Colorectal Cancer (mCRC), Hepatocellular Carcinoma (HCC)

9.3. Global Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Cancer Treatment Centers, Ambulatory Surgical Centers, Research Institutes

10. Cyramza (Ramucirumab) Market Regional And Country Analysis

10.1. Global Cyramza (Ramucirumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cyramza (Ramucirumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cyramza (Ramucirumab) Market

11.1. Asia-Pacific Cyramza (Ramucirumab) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cyramza (Ramucirumab) Market

12.1. China Cyramza (Ramucirumab) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cyramza (Ramucirumab) Market

13.1. India Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cyramza (Ramucirumab) Market

14.1. Japan Cyramza (Ramucirumab) Market Overview

14.2. Japan Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cyramza (Ramucirumab) Market

15.1. Australia Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Cyramza (Ramucirumab) Market

16.1. South Korea Cyramza (Ramucirumab) Market Overview

16.2. South Korea Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Cyramza (Ramucirumab) Market

17.1. Western Europe Cyramza (Ramucirumab) Market Overview

17.2. Western Europe Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Cyramza (Ramucirumab) Market

18.1. UK Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Cyramza (Ramucirumab) Market

19.1. Germany Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Cyramza (Ramucirumab) Market

20.1. France Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Cyramza (Ramucirumab) Market

21.1. Eastern Europe Cyramza (Ramucirumab) Market Overview

21.2. Eastern Europe Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Cyramza (Ramucirumab) Market

22.1. North America Cyramza (Ramucirumab) Market Overview

22.2. North America Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Cyramza (Ramucirumab) Market

23.1. USA Cyramza (Ramucirumab) Market Overview

23.2. USA Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Cyramza (Ramucirumab) Market

24.1. Canada Cyramza (Ramucirumab) Market Overview

24.2. Canada Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Cyramza (Ramucirumab) Market

25.1. South America Cyramza (Ramucirumab) Market Overview

25.2. South America Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Cyramza (Ramucirumab) Market

26.1. Middle East Cyramza (Ramucirumab) Market Overview

26.2. Middle East Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Cyramza (Ramucirumab) Market

27.1. Africa Cyramza (Ramucirumab) Market Overview

27.2. Africa Cyramza (Ramucirumab) Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Cyramza (Ramucirumab) Market Regulatory and Investment Landscape

29. Cyramza (Ramucirumab) Market Competitive Landscape And Company Profiles

29.1. Cyramza (Ramucirumab) Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Cyramza (Ramucirumab) Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Cyramza (Ramucirumab) Market Company Profiles

29.3.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30. Global Cyramza (Ramucirumab) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Cyramza (Ramucirumab) Market

32. Cyramza (Ramucirumab) Market High Potential Countries, Segments and Strategies

32.1 Cyramza (Ramucirumab) Market In 2030 - Countries Offering Most New Opportunities

32.2 Cyramza (Ramucirumab) Market In 2030 - Segments Offering Most New Opportunities

32.3 Cyramza (Ramucirumab) Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cyramza (Ramucirumab) Market, Overview Of Key Products - Product Examples

Table 2: Global Cyramza (Ramucirumab) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cyramza (Ramucirumab) Market, Supply Chain Analysis

Table 4: Global Cyramza (Ramucirumab) Market, Major Raw Material Providers

Table 5: Global Cyramza (Ramucirumab) Market, Major Resource Providers

Table 6: Global Cyramza (Ramucirumab) Market, Major Manufacturers (Suppliers)

Table 7: Global Cyramza (Ramucirumab) Market, Major Distributors And Channel Partners

Table 8: Global Cyramza (Ramucirumab) Market, Key Technologies & Future Trends

Table 9: Global Cyramza (Ramucirumab) Market, Major Trends

Table 10: Global Cyramza (Ramucirumab) Market, Major End Users

Table 11: Global Cyramza (Ramucirumab) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cyramza (Ramucirumab) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cyramza (Ramucirumab) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cyramza (Ramucirumab) Market - TAM, US$ Billion, 2025

Table 15: Global Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cyramza (Ramucirumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cyramza (Ramucirumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Cyramza (Ramucirumab) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Cyramza (Ramucirumab) Market - Company Scoring Matrix

Table 73: Eli Lilly and Company Financial Performance

Table 74: Global Cyramza (Ramucirumab) Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Cyramza (Ramucirumab) Market, Competitive Dashboard

Table 76: Global Cyramza (Ramucirumab) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Cyramza (Ramucirumab) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 78: Global, Cyramza (Ramucirumab) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 79: Global, Cyramza (Ramucirumab) Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Cyramza (Ramucirumab) Market, Overview Of Key Products - Product Examples

Figure 2: Global Cyramza (Ramucirumab) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cyramza (Ramucirumab) Market, Supply Chain Analysis

Figure 4: Global Cyramza (Ramucirumab) Market, Major Raw Material Providers

Figure 5: Global Cyramza (Ramucirumab) Market, Major Resource Providers

Figure 6: Global Cyramza (Ramucirumab) Market, Major Manufacturers (Suppliers)

Figure 7: Global Cyramza (Ramucirumab) Market, Major Distributors And Channel Partners

Figure 8: Global Cyramza (Ramucirumab) Market, Key Technologies & Future Trends

Figure 9: Global Cyramza (Ramucirumab) Market, Major Trends

Figure 10: Global Cyramza (Ramucirumab) Market, Major End Users

Figure 11: Global Cyramza (Ramucirumab) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cyramza (Ramucirumab) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cyramza (Ramucirumab) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cyramza (Ramucirumab) Market - TAM, US$ Billion, 2025

Figure 15: Global Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cyramza (Ramucirumab) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cyramza (Ramucirumab) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Cyramza (Ramucirumab) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Cyramza (Ramucirumab) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Cyramza (Ramucirumab) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Cyramza (Ramucirumab) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Cyramza (Ramucirumab) Market - Company Scoring Matrix

Figure 73: Eli Lilly and Company Financial Performance

Figure 74: Global Cyramza (Ramucirumab) Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Cyramza (Ramucirumab) Market, Competitive Dashboard

Figure 76: Global Cyramza (Ramucirumab) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Cyramza (Ramucirumab) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 78: Global, Cyramza (Ramucirumab) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 79: Global, Cyramza (Ramucirumab) Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Biopreservation Market Report 2026 - Global Outlook – By Type (Biopreservation Equipment, Biopreservation Media), By Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens), By Application (Therapeutic...

Guillain-Barre Syndrome Market Report 2026 - Global Outlook – By Type (Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Miller Fisher Syndrome (MFS), Acute Motor Axonal Neuropathy (AMAN)), By Therapeutics (Intrave...

Ranibizumab Market Report 2026 - Global Outlook – By Product (Single Use Prefilled Syringe, Single Use Glass Vial), By Application (Wet Age Related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Diabetic Macular ...

Cyclohexylbenzene Market Report 2026 - Global Outlook – By Product Type (Standard, High Purity), By Application (Plastics, Paints And Coatings, Adhesives, Electrical And Electronics, Chemical Production), By End-Use Indu...

Bevacizumab Biosimilars Market Report 2026 - Global Outlook – By Product (Avastin, Mvasi, Zirabev, Aybintio, Other Products), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distributi...

Benzodiazepine Drugs Market Report 2026 - Global Outlook – By Product (Alprazolam, Diazepam, Lorazepam, Clonazepam, Temazepam, Oxazepam, Chlordiazepoxide, Other Products), By Route Of Administration (Oral, Parenteral, Ot...

Pontine Glioma Drugs Market Report 2026 - Global Outlook – By Type (Diffuse Brain Stem Glioma, Focal Brain Stem Glioma, Recurrent Brain Stem Glioma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Appli...

Frequently Asked Questions

How big is the Cyramza (Ramucirumab) Market?

The Cyramza (Ramucirumab) market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Cyramza (Ramucirumab) market growth?

The global Cyramza (Ramucirumab) market is expected to grow at a CAGR of 6.3% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Cyramza (Ramucirumab) market?

Some Key Players in the Cyramza (Ramucirumab) market Include, Eli Lilly and Company .

What is the anticipated growth trend for the Cyramza (Ramucirumab) market?

Major trend in this market includes: nan. For further insights on this market. request a sample here

Which region has the most growth potential in the Cyramza (Ramucirumab) market?

North America was the largest region in the cyramza (ramucirumab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cyramza (ramucirumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.